Fundz

Ray Therapeutics, Inc. reported raising $6 Million in an initial SEC Form D filing, from an offering of $6 Million

PRIVATEApr 05, 2022

Amount Raised

$6 Million

$6 Million sold, per SEC Form D (first sale Apr 5, 2022)

Round Type

Venture

San DiegoBiotechnologyHealth CareScience And Engineering

Quick answer

Ray Therapeutics raised $6 Million in a funding round, dated April 5, 2022. Ray Therapeutics is based in San Diego, California, United States.

How much did Ray Therapeutics raise?
Ray Therapeutics raised $6 Million in a funding round on April 5, 2022.
What does Ray Therapeutics do?
Ray Therapeutics Inc (RayTx) is a late-stage preclinical Bay Area biotechnology company pioneering the first-to-market precision optogenetic therapy for vision restoration that is highly active in ambient lighting (and..
Where is Ray Therapeutics based and how big is it?
Ray Therapeutics is based in San Diego, California, United States. Fundz records about 33 employees.
Who are the decision-makers at Ray Therapeutics?
Fundz holds 1 contact at Ray Therapeutics, including the Sr Director, CMC Analytical. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Science And Engineering and Biotechnology around the same time

Companies in the same sectors as Ray Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Vyriad raised $30M (Series B) on May 17, 2022.
  • Aspen Neuroscience raised $375K (Seed) on May 10, 2022.
  • Moma Therapeutics raised $150M (Series B) on May 10, 2022.
  • Sequentify raised $7M (Funding Round) on May 10, 2022.
  • Hemispherian AS raised an undisclosed amount (Seed) on May 3, 2022.
  • Haya Therapeutics raised an undisclosed amount (Funding Round) on May 3, 2022.

Who to call at Ray Therapeutics, and when

A new round usually means Ray Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Ray Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Ray Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Ray Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Ray Therapeutics

Location

3625 Dudley Street

San Diego, California, United States

About

Ray Therapeutics Inc (RayTx) is a late-stage preclinical Bay Area biotechnology company pioneering the first-to-market precision optogenetic therapy for vision restoration that is highly active in ambient lighting (and will not require light-enhancing goggles). Our studies have shown for the first time that our proprietary ChRown optogenetic protein can restore high levels of visual acuity, contrast sensitivity and visual field. RayTx lead asset, RTx-015, is expected to address the huge unmet medical in people suffering from many forms of retinal blindness (independent of the underlying genetic cause), including those with advanced age-related macular degeneration. RayTx has partnered with a world-leading AAV gene therapy manufacturer is utilizing their proprietary commercial manufacturing process and analytics to maximally de-risk clinical development. RayTx anticipates clinical trials will begin by the end of 2023 in our initial indication, retinitis pigmentosa.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Ray Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsVidya S., Sr Director, CMC Analytical hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Ray Therapeutics's next move

See what Strategic adds

Ray Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.